New MMR vaccine shows promise in protecting kids against measles, mumps, and rubella
NCT ID NCT06399003
First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 19 times
Summary
This study tested a new measles, mumps, and rubella (MMR) vaccine made by Shanghai Institute of Biological Products in 1,200 healthy children aged 9-11 months. The goal was to see if it works as well as a licensed GSK vaccine and is safe. Children received one dose, and researchers checked their immune response and any side effects for 42 days after vaccination.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEASLES-MUMPS-RUBELLA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Victoria Biomedical Research Institute(VIBRI)
Kisumu, Kenya
Conditions
Explore the condition pages connected to this study.